推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 2014年第二季度和第三季度的藥品抽檢結(jié)果顯示，湖北省藥品質(zhì)量狀況總體良好，合格率超過93%。在不合格產(chǎn)品當(dāng)中，中藥飲片占比較高，將是監(jiān)管的重中之重。
24日，省食藥監(jiān)局公布了上述結(jié)果。2014年第二季度和三季度，湖北省分別抽檢了764個(gè)品種1360批次和1581個(gè)品種4681批次的藥品。二季度75批次不合格，合格率94.5%；三季度315批次不合格，合格率93.3%。二季度有15個(gè)批次的不合格中藥材，非標(biāo)示企業(yè)生產(chǎn)；在湖北李時(shí)珍中藥材專業(yè)市場有限公司多家藥行檢出的白芍、黃芪、枸杞子、黃芩、山藥等中藥材，二氧化硫殘留量超標(biāo)。而三季度的不合格產(chǎn)品中，包括一些在地方醫(yī)院銷售的中藥飲片。
一些常用藥也查出不合格產(chǎn)品。如注射用頭孢噻肟鈉(上海新亞藥業(yè)有限公司，批號(hào)130533)、消炎止咳片(通化斯威藥業(yè)股份有限公司，批號(hào)130404)、烏雞白鳳丸(湖北金龍福藥業(yè)有限公司，批號(hào)20130601)、抗病毒口服液(武漢金聯(lián)藥業(yè)有限公司，批號(hào)20140301)、復(fù)方丹參片(湖北諾得勝制藥有限公司，批號(hào)140401)、板藍(lán)根顆粒(赤峰天奇制藥有限責(zé)任公司，批號(hào)20130206)等。
省食藥監(jiān)部門還公告了一批假冒藥品(詳見省食藥監(jiān)局網(wǎng)站)，將追根溯源，查清購銷渠道。
